FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
October 11, 2007
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: October 11, 2007
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Timing of Smith & Nephew third quarter results
11 October 2007
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business,
will be announcing its results for the third quarter ending 29 September 2007 on
Thursday 1 November 2007 at 12 noon GMT/8.00am Eastern. This will be followed
by a conference call with financial analysts at 1.00pm GMT/9.00am Eastern, which
can be heard live via webcast on the Smith & Nephew website at
www.smith-nephew.com and available on the site archive shortly afterwards.
About Us
Smith & Nephew is a global medical technology business, specialising in
Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy
and Advanced Wound Management products. Smith & Nephew is a global leader in
arthroscopy and advanced wound management and is one of the leading global
orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust. The Company operates in 32
countries around the world. Annual sales in 2006 were nearly $2.8 billion.
Enquiries:
Investors/Analysts
Julie Allen Tel: +44 (0)20 7401 7646
Corporate Affairs Co-ordinator
Smith & Nephew plc
Media
Jon Coles +44 (0) 20 7404 5959
Brunswick - London
Cindy Leggett-Flynn +1 (212) 333 3810
Brunswick - New York